Abstract:Jie Liu, Lijuan Lu, Yu Wei, Yu Li, Qiong Wang, Lei Yu, Langen Zhuang, Guoxi Jin, Xiaoyan Pei Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui Province, People's Republic of China Correspondence: Guoxi Jin; Xiaoyan Pei, Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University, No. 287 Changhuai Road, Bengbu, Anhui Province, 233000, People's Republic of China, Email ; Pseudohypoparathyroidism (PHP) is a rare genetic disease characterized by hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone (PTH) in serum. Here, we report a case of a patient with pseudohypoparathyroidism type IB (PHPIB) and subclinical hypothyroidism, analyze the clinical and genetic data of his family members, review the relevant literature, and classify and discuss the pathogenesis and clinical characteristics of each subtype. Finally, we discuss the treatment approach to improve clinicians' understanding of the disease. Keywords: hypocalcemia, parathyroid hormone resistance, GNAS, STX16, molecular genetic mechanism Pseudohypoparathyroidism (PHP) is a rare hereditary endocrine disease with high heterogeneity. The molecular genetic mechanism of PHP is related to an inactivation mutation or an epigenetic modification of the GNAS gene, which encodes stimulating G protein α subunit (Gsα). 1 The change in the GNAS gene leads to a decrease in Gsα activity, so it cannot activate the downstream adenylate cyclase system to produce the second messenger cyclic adenosine monophosphate (cAMP). Finally, the inhibition of the Gsα/cAMP/protein kinase A (PKA) signaling pathway produces a series of pathological reactions. 2 The first symptoms are usually those of tetany due to low calcium, and some patients have epileptic seizures. In other cases, the first symptoms are skin heterotopic ossification, congenital hypothyroidism, or dwarfism. The main feature of the disease is the resistance of target organs (bone and kidney) to parathyroid hormone (PTH), which results in hypocalcemia, hyperphosphatemia, and elevated serum PTH concentration. Other clinical manifestations include ectopic calcification (especially in the basal ganglia and lens), ectopic ossification (most often in the dermis and subcutaneous fat), and Albright hereditary osteodystrophy (AHO). In some cases, resistance to other hormones such as thyroid-stimulating hormone (TSH), growth hormone–releasing hormone (GHRH), and follicle-stimulating hormone (FSH)/luteinizing hormone (LH) may also occur. 3,4 A 32-year-old woman was admitted to the neurology outpatient clinic of our hospital for "dizziness and headache for 2 weeks." She did not experience nausea and vomiting. Head computed tomography (CT) showed bilateral symmetrical high-density shadows in the basal ganglia that resembled those in metabolic lesions (Figure 1). The concentrations of biochemical parameters were as follows: total calcium, 2.18 (normal range, 2.11–2.52) mmol/L; inorganic phosphorus, 1.40 (normal range, 0.85–1.51) mmol/L; PTH, 231 (normal range, 12–88) pg/mL. She was then transferred to the endocrinology outpatient clinic and admitted to the hospital. Her medical history revealed that she had seen a doctor in another hospital 4 years ago because of facial and limb convulsions. At that time, the following parameters were measured: calcium, 1.43 (2.11–2.52) mmol/L; PTH, 439.70 (12–88) pg/mL; thyroxine, 84.70 (55.34–160.88) nmol/L; TSH, 5.96 (0.40–4.34) mIU/L; on that basis, the patient was diagnosed with "hypocalcemia" and "subclinical hypothyroidism." She was discharged with symptomatic treatment, including supplementation of calcium, vitamin D, and thyroid hormone. She usually took calcium tablets (details unknown) and did not undergo follow-up examinations. She denied any history of chronic disease and surgery but reported that her brother had a history of hypocalcemia. There was no genetic history in the family. Physical examination revealed the following: blood pressure, 100/75 mm Hg; height, 160 cm; weight, 55.5 kg; BMI, 21.7 kg/m2; clear mind, normal development, good nutrition; no abnormalities of the heart, lungs, and abdomen; no obvious abnormalities of the spine and limbs; Chvostek sign, Trousseau sign, and peroneal nerve reflex were all negative. Figure 1 Head CT. Related examination on the first day of hospitalization: total calcium, 1.96 (2.11–2.52) mmol/L; ionized calcium 1.05 (1.10–1.34) mmol/L; inorganic phosphorus 1.25 (0.85–1.51) mmol/L; 25-hydroxyvitamin D, 19.91 (>20) ng/mL; urinary calcium, 2.91 (2.50–7.50) mmol/L; urinary phosphorus, 7.44 (32.3–38.4) mmol/L; free thyroxine 17.53 (10.43–24.32) pmol/L; TSH, 6.31 (0.40–4.34) mIU/L. There were no obvious abnormalities in blood routine, urine routine, liver and kidney function parameters, bicarbonate, se -Abstract Truncated-

STX16 exon 5–7 deletion in a patient with pseudohypoparathyroidism type 1B

A novel long-range deletion spanning STX16 and NPEPL1 causing imprinting defects of the GNAS locus discovered in a patient with autosomal-dominant pseudohypoparathyroidism type 1B

[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

Identification of a Novel Mutation in Pseudohypoparathyroidism Type Ia in a Chinese Family

Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature

Genetic and Epigenetic Characteristics of Autosomal Dominant Pseudohypoparathyroidism Type 1B: Case Reports and Literature Review

Progression of PTH Resistance in Autosomal Dominant Pseudohypoparathyroidism Type Ib Due to Maternal STX16 Deletions

Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal STX16 deletion

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report

Identification of a novel GNAS mutation for pseudohypoparathyroidism in a Chinese family

Genetics of Pseudohypoparathyroidism

Preferential Maternal Transmission of STX16-GNAS Mutations Responsible for Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B): Another Example of Transmission Ratio Distortion

Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report

Genotype-phenotype Correlations in Pseudohypoparathyroidism Type 1a Patients: a Systemic Review.

A Novel GNAS Mutation in Pseudohypoparathyroidism Type 1a in a Chinese Man Presented with Recurrent Seizure: a Case Report

Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review

Analysis of Clinical Characteristics on a Hybrid Deletion Mutation of GNAS-AS1 Gene Exon 5E Leading to Pseudohypoparathyroidism with Hypokalemia and Hypomagnesemia

Abnormal Methylation Status of the GNAS Exon 1A Region in Pseudohypohyperparathyroidism Combined With Turner Syndrome

Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A

Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism

Genetic Analysis of Pseudohypoparathyroidism Type Ⅰ a : Report of a Pedigree